Edition:
India

People: Biomarin Pharmaceutical Inc (BMRN.OQ)

BMRN.OQ on NASDAQ Stock Exchange Global Select Market

77.53USD
23 Oct 2020
Change (% chg)

$-1.64 (-2.07%)
Prev Close
$79.17
Open
$79.50
Day's High
$79.57
Day's Low
$76.55
Volume
439,893
Avg. Vol
722,597
52-wk High
$131.86
52-wk Low
$68.25

Ajer, Jeff 

Mr. Jeff Robert Ajer serves as an Executive Vice President, Chief Commercial Officer of BioMarin Pharmaceutical Inc. Mr. Ajer joined BioMarin in August 2005 and currently serves as our Executive Vice President and Chief Commercial Officer. From October 2012 to January 2014, Mr. Ajer served as our Senior Vice President and Chief Commercial Officer. From April 2009 to October 2012, Mr. Ajer served as our Vice President, Commercial Operations, The Americas, where he had responsibility for commercial operations throughout the Americas and led product marketing, reimbursement, and sales operations for BioMarin. Prior to joining BioMarin, Mr. Ajer served in various roles at Genzyme Corporation (Genzyme) beginning in November 2003 and lastly as Vice President, Global Transplant Operations from December 2004 to August 2005. Mr. Ajer’s experience prior to Genzyme includes roles in sales, marketing and operations at SangStat Medical Corporation and ICN Pharmaceuticals, Inc. Mr. Ajer received both a B.S. in chemistry and an M.B.A. from the University of California, Irvine. Mr. Ajer is currently a Director of Nektar Therapeutics, a public biopharmaceutical company.

Basic Compensation

Total Annual Compensation, USD 580,192
Restricted Stock Award, USD 4,303,660
Long-Term Incentive Plans, USD --
All Other, USD 1,460,470
Fiscal Year Total, USD 6,344,320

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Jean-Jacques Bienaime

18,405,900

Brian Mueller

--

Henry Fuchs

7,017,500

C. Greg Guyer

--

G. Eric Davis

2,708,210

Jeff Ajer

6,344,320
As Of  31 Dec 2019